ClinVar Miner

Submissions for variant NM_000322.5(PRPH2):c.634A>G (p.Ser212Gly)

dbSNP: rs61755800
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
NEI Ophthalmic Genomics Laboratory, National Institutes of Health RCV000504657 SCV001424602 likely pathogenic Retinitis pigmentosa 2020-01-07 criteria provided, single submitter clinical testing The variant NM_000322.4:c.634A>G in the PRPH2 gene has been previously studied(PMIDs 1427912, 18050133, 30924848). We found this variant in 1 patient(s) in a PRPH2 cohort study (Reeves et al. 2020). This variant is listed in dbSNP and/or HGMD (rs61755800,CM920606). It is absent in gnomAD browser. It is not enriched in the PRPH2 disease cohort. We invoked ACMG criteria [PP1-M, PM1, PM2, PM5, PP3, PP5] and classified NM_000322.4:c.634A>G in the PRPH2 gene as a Likely Pathogenic mutation.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000085000 SCV001446851 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001854491 SCV002243017 pathogenic PRPH2-related disorder 2022-09-07 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PRPH2 protein function. ClinVar contains an entry for this variant (Variation ID: 98689). This missense change has been observed in individuals with PRPH2-related conditions (PMID: 1427912, 18050133; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 212 of the PRPH2 protein (p.Ser212Gly).
Dept Of Ophthalmology, Nagoya University RCV003888459 SCV004707340 likely pathogenic Retinal dystrophy 2023-10-01 criteria provided, single submitter research
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg RCV003888459 SCV005070977 likely pathogenic Retinal dystrophy 2020-01-01 criteria provided, single submitter clinical testing
Retina International RCV000085000 SCV000117136 not provided not provided no assertion provided not provided
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504657 SCV000598703 likely pathogenic Retinitis pigmentosa 2015-01-01 no assertion criteria provided research
Leiden Open Variation Database RCV000085000 SCV001745094 likely pathogenic not provided 2021-04-06 no assertion criteria provided curation Curator: Global Variome, with Curator vacancy. Submitters to LOVD: LOVD, Manon Peeters, Yoshito Koyanagi.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.